These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7836783)

  • 1. Difference and ratio plots: simple tools for improved presentation and interpretation of scientific data. Unexpected possibilities for the use of the conglutinin binding assay in inflammatory rheumatic diseases.
    Svendsen A; Holmskov U; Petersen PH; Jensenius JC
    J Immunol Methods; 1995 Jan; 178(2):211-8. PubMed ID: 7836783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conglutinin binding polyethylene glycol precipitation assay for immune complexes.
    Macanovic M; Lachmann PJ
    Clin Exp Immunol; 1979 Nov; 38(2):274-83. PubMed ID: 118838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical relevance of circulating immune complexes in patients with systemic lupus erythematosus and chronic polyarthritis].
    Menzel EJ; Smolen JS; Knapp W; Scherak O; Steffen C
    Acta Med Austriaca; 1979; 6(5):212-4. PubMed ID: 162334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Demonstration of C3-binding circulating immune complexes using Raji, conglutinin and anti-C3 assays--a critical review].
    Arndt R
    Immun Infekt; 1984 Feb; 12(1):3-11. PubMed ID: 6241918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L; Maini RN
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune complexes in the rheumatic diseases.
    McDuffie FC
    J Allergy Clin Immunol; 1978 Jul; 62(1):37-43. PubMed ID: 149152
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation and clinical significance of circulating immune complexes.
    Theofilopoulos AN
    Prog Clin Immunol; 1980; 4():63-106. PubMed ID: 6247742
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sedimentation of circulating immune complexes with polyethylene glycol combined with immunoenzyme method--a new approach to analysis of circulating immune complexes in the sera of patients with rheumatic diseases].
    Timofeeva EB; Nasonov EL; Sura VV; Samoriadova OS; Baranauskaĭte AA
    Revmatologiia (Mosk); 1991; (2):26-8. PubMed ID: 1833807
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of complement].
    Wellek B; Opferkuch W
    Dtsch Med Wochenschr; 1973 Dec; 98(49):2356-61. PubMed ID: 4271713
    [No Abstract]   [Full Text] [Related]  

  • 10. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases.
    Cook AD; Mackay IR; Cicuttini FM; Rowley MJ
    J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation and significance of circulating immunocomplexes and their correlation with other immunologic parameters in connective tissue diseases].
    Rodrigo MJ; Fonollosa V; Vilardell M; Codina R; Lience E; Schwartz S
    Med Clin (Barc); 1990 Sep; 95(7):241-6. PubMed ID: 2283896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.
    Lachmann PJ; Macanovic M; Harkiss GD; Oldroyd RG; Habicht J
    Clin Exp Immunol; 1981 Nov; 46(2):250-8. PubMed ID: 6279342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
    Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
    Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid arthritis and systemic lupus erythematosus as immune complex diseases.
    Weissmann G
    Bull NYU Hosp Jt Dis; 2009; 67(3):251-3. PubMed ID: 19852746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional analysis of immune complex-rich serum fractions in autoimmune diseases by in vitro C3 activation of fresh blood].
    Böhm U; Merétey K; Falus A; Bozsóky S
    Z Rheumatol; 1981; 40(3):126-30. PubMed ID: 6456623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of immune-complex assays in diagnosis and management.
    Pussell BA; Lockwood CM; Scott DM; Pinching AJ; Peters DK
    Lancet; 1978 Aug; 2(8085):359-64. PubMed ID: 79721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complement deficiencies].
    Meri S
    Duodecim; 1994; 110(2):185-94. PubMed ID: 7555791
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibronectin and immune complexes in rheumatic diseases].
    Mazepa MA
    Vestn Akad Med Nauk SSSR; 1991; (4):57-61. PubMed ID: 1830993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphology of immune inflammation in rheumatic diseases].
    Strukov AI; Kop'eva TN; Makarova OV
    Arkh Patol; 1983; 45(11):44-50. PubMed ID: 6142706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complex-mediated rheumatic diseases: the evidence and the enigmas.
    Williams RC
    Postgrad Med; 1980 Nov; 68(5):124-31, 133. PubMed ID: 6448996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.